tivunatamig (PF-08634404) - Pfizer
PF-08634404 A PD-1 × VEGF bispecific antibody induces VEGF-dependent PD-1 degradation to enhance checkpoint inhibition (SITC 2026) - Oct 2, 2026 - Abstract #666; Pres time: Nov 7, 2026; 10:00 AM - 08:10 PM; Location: PCC - Lower Level - North Exhibition Halls 4-5-6; No abstract available 
Bispecific • Checkpoint inhibition • Oncology
https://www.sitcancer.org/2026/abstracts/titles-and-publications?SITC%202026%20Abstracts%5BhitsPerPage%5D=100
 
Laila Shehata; Eliana Moskovitz; Weiping Zeng; Yuqing Zhang; Michelle Ulrich; Rebecca Mazahreh; Meghan Zuck; Catalina Sakai; Markus Carlson; Matthew Rathgeber; Sherif Abdelhamed; Brian O'Connor; Joseph Dekker; Gregory Szeto; Ryan Heiser
 
Oct 2, 2026
 
Prev Next